Literature DB >> 16291072

Critical role of actin in modulating BBB permeability.

Char-Huei Lai1, Kuo-Hsing Kuo, Joyce M Leo.   

Abstract

A major obstacle in the treatment of degenerative manifestations and debilitating diseases in the central nervous system (CNS) lies in the impediment of drug delivery into these tissues. The impediment is due to a membrane barrier referred to as the blood-brain barrier (BBB). It is known that the BBB is a unique membranous structure in brain capillaries that tightly segregates the brain from systemic blood circulation. It is imperative to have a thorough understanding of the molecular components and their integrated function of this barrier to develop effective therapeutics for CNS disorders and diseases. Although there are other cell and biochemical properties that underlie this barrier function, it is well established that the barrier is mainly made up of the physical elements of tight junction (TJ) complex. The major constituents of TJ, such as occludin, claudins, zonula occludens (ZOs) and junctional adhesion molecule (JAM) have been subjects of intensive studies and reviews. However, after examining currently proposed models, we have come to believe that a cytoskeletal component-actin may play a critical role in interacting TJ molecular constituents and modulating functional TJ complex. In this review, we will discuss the correlation of temporal and spatial distribution and remodeling of actin filaments with altering integrity of TJ complexes in various systems and present a hypothesis to depict its potential role in modulating BBB permeability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291072     DOI: 10.1016/j.brainresrev.2005.03.007

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  38 in total

Review 1.  Targeting the neurovascular unit for treatment of neurological disorders.

Authors:  Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

2.  Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.

Authors:  Zhen Li; Xiao-Bai Liu; Yun-Hui Liu; Yi-Xue Xue; Jing Liu; Hao Teng; Zhuo Xi; Yi-Long Yao
Journal:  J Mol Neurosci       Date:  2015-10-31       Impact factor: 3.444

3.  Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.

Authors:  Itzik Cooper; David Last; David Guez; Shirley Sharabi; Shirin Elhaik Goldman; Irit Lubitz; Dianne Daniels; Sharona Salomon; Gregory Tamar; Tzur Tamir; Ronni Mardor; Mati Fridkin; Yoram Shechter; Yael Mardor
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

Review 4.  Neuron-glial interactions in blood-brain barrier formation.

Authors:  Swati Banerjee; Manzoor A Bhat
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

Review 5.  Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4.

Authors:  J Marc Simard; Kristopher T Kahle; Volodymyr Gerzanich
Journal:  J Neurosurg       Date:  2010-09       Impact factor: 5.115

6.  Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage.

Authors:  J Marc Simard; Zhihua Geng; S Kyoon Woo; Svetlana Ivanova; Cigdem Tosun; Ludmila Melnichenko; Volodymyr Gerzanich
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-15       Impact factor: 6.200

Review 7.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

8.  Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells.

Authors:  P Hülper; S Veszelka; F R Walter; H Wolburg; P Fallier-Becker; J Piontek; I E Blasig; M Lakomek; W Kugler; M A Deli
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Deficiency of vasodilator-stimulated phosphoprotein (VASP) increases blood-brain-barrier damage and edema formation after ischemic stroke in mice.

Authors:  Peter Kraft; Peter Michael Benz; Madeleine Austinat; Marc Elmar Brede; Kai Schuh; Ulrich Walter; Guido Stoll; Christoph Kleinschnitz
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

10.  Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.

Authors:  Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.